Company Overview and News

 
FAST / Fastenal Co. 10-Q (Quarterly Report)

2018-04-16 sec.gov
Document Table of Contents
Upvote Downvote

 
3 Stocks to Watch on Friday: Fastenal Company (FAST), General Electric Company (GE) and Intel Corporation (INTC) | InvestorPlace

2018-04-13 investorplace
U.S. equities were surging on Thursday as global tensions eased a bit, despite President Trump saying that the missile strike on Syria “could be very soon or not soon at all.” The S&P 500 Index gained 0.8%, the Dow Jones Industrial Average is up 1.2% and the Nasdaq Composite gained 1%.
Upvote Downvote

 
Wednesday’s Biggest Winners and Losers in the S&P 500

2018-04-11 247wallst
Wednesday was a down day for the broad U.S. markets with all three major indices pulling back after putting together a few consecutive days of gains. The pullback was not as bad as maybe would be expected considering the volatility. Facebook’s CEO Mark Zuckerberg continued his testimony on Capitol Hill, but tech stocks were less enthusiastic in Wednesday’s session. Crude oil made another solid day of gains.
Upvote Downvote

 
Fastenal Company Stock Falls on Q1 Earnings Results

2018-04-11 investorplace
Fastenal Company (NASDAQ:FAST) stock took a hit on Wednesday following the release of its earnings report for the first quarter of 2018.
Upvote Downvote

 
Weekly Wrap: The Sounds Of Uncertainty

2018-04-07 seekingalpha
That, in a nutshell, sums up the wide gyrations in the stock market this week as both President Trump and China engaged in a "mine is bigger than yours" round of tariff announcements. While the stock market attempted to shrug these off, the reality is additional rounds add to what is likely to be tension filled talks as both sides look to claim victory while saving face. Now let's get into the nitty-gritty of the past week .
Upvote Downvote

 
Is the Bark of Amazon.com, Inc. Worse Than Its Bite?

2018-04-02 investorplace
I’ve been bullish on Amazon.com, Inc. (NASDAQ:AMZN) stock for some time now — and so has the market. Even with a 10% pullback in the last couple of weeks, the gains in Amazon stock have been incredible. AMZN stock is up nearly 50% just since late October. It has risen 65% in the past year — and has nearly quadrupled in the last three.
Upvote Downvote

 
Top Analyst Upgrades and Downgrades: AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical, Unilever and More

2018-03-19 247wallst
The market finished higher Friday, finally posting some gains after struggling most of the week with concerns over trade tariffs and the potential for a trade war. The futures are lower Monday morning as investors look for more direction on trade and also are listening closely for any commentary on interest rates, as the Federal Reserve is expected to lift rates later this week.
Upvote Downvote

 
FAST / Fastenal Co. DEFINITIVE NOTICE AND PROXY STATEMENT

2018-02-26 sec.gov
Document SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Definitive Proxy Statement ¨ Definitive Additional Materials ¨ Soliciting Material Under
Upvote Downvote

 
FAST / Fastenal Co. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
fastenalco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Fastenal Co     Title of Class of Securities:  Common Stock     CUSIP Number:  311900104     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   
Upvote Downvote

 
FAST / Fastenal Co. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
fastenalco.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  Fastenal Co     Title of Class of Securities:  Common Stock     CUSIP Number:  311900104     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-1(b)   
Upvote Downvote

 
FAST / Fastenal Co. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-07 fintel.io
Fastenal Co. (NASDAQ:FAST) has 675 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 246,050,873 shares. Largest shareholders include Vanguard Group Inc, BlackRock Inc., Bank of New York Mellon Corp, State Street Corp, Wellington Management Group Llp, Route One Investment Company, L.P., Oppenheimer Funds Inc, Waddell & Reed Financial Inc, Wedgewood Partners Inc, and Bares Capital Management, Inc.
Upvote Downvote

 
FAST / Fastenal Co. / Bank of New York Mellon Corp - 3G/A (Passive Investment)

2018-02-07 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.3)* NAME OF ISSUER: Fastenal Company TITLE OF CLASS OF SECURITIES: Common Stock CUSIP NUMBER: 311900104 DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT: December 31, 2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shal
Upvote Downvote

 
FAST / Fastenal Co. / Bank of New York Mellon Corp - 3G/A (Passive Investment)

2018-02-07 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.3)* NAME OF ISSUER: Fastenal Company TITLE OF CLASS OF SECURITIES: Common Stock CUSIP NUMBER: 311900104 DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT: December 31, 2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shal
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 311900104